MAPK8 and tuberculosis: The anti-TB drug SQ109 has been shown to activate both the p38 and JNK pathways, thereby enhancing M1 macrophage polarization, apoptosis, and the production of cytokines such as IL-6, IL-12, and IFN-γ (Singh et al., 2022).